Surescripts Settles FTC Monopoly Charges: Impact on Electronic Prescription Marketplace and Health Tech Sector
In a significant development that shores up competition in the electronic prescription marketplace, Surescripts entered into a settlement with the U.S. Federal Trade Commission (FTC). The health information technology company was facing allegations of monopolistic conduct in violation of the FTC Act. Charges pressed against Surescripts revolved around purported actions that constrained customer choice, sabotaged…